Kim J,  Kim S, Jeon S, Hui Z, Kim Y, Im Y, Lim W, Kim Ch,  Choi H, Kim O. Anti-inflammatory effects of zinc in PMA-treated human gingival fibroblast cells. Med Oral Patol Oral Cir Bucal. 2015 Mar 1;20 (2):e180-7.

 

 

doi:10.4317/medoral.19896

http://dx.doi.org/doi:10.4317/medoral.19896

 

 

 

1. Shashy RG, Ridley MB. Aphthous ulcers: a difficult clinical entity. American journal of otolaryngology. 2000;21:389-93.
http://dx.doi.org/10.1053/ajot.2000.18872

 

2. Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M. Recurrent aphthous stomatitis. Quintessence international. 2000;31:95-112.

 

3. Lewkowicz N, Lewkowicz P, Kurnatowska A, Banasik M, Glowacka E, Cedzyński M, et al. Innate immune system is implicated in recurrent aphthous ulcer pathogenesis. J Oral Pathol Med. 2003;32:475-81.
http://dx.doi.org/10.1034/j.1600-0714.2003.00181.x

 

4. Lin SS, Chou MY, Ho CC, Kao CT, Tsai CH, Wang L, et al. Study of the viral infections and cytokines associated with recurrent aphthous ulceration. Microbes and infection / Institut Pasteur. 2005;7:635-44.
http://dx.doi.org/10.1016/j.micinf.2004.12.023

 

5. Karaca S, Seyhan M, Senol M, Harputluoglu MM, Ozcan A. The effect of gastric Helicobacter pylori eradication on recurrent aphthous stomatitis. International journal of dermatology. 2008;47:615-7.
http://dx.doi.org/10.1111/j.1365-4632.2008.03667.x

 

6. Patil CS, Kirkwood KL. p38 MAPK signaling in oral-related diseases. J Dent Res. 2007;86:812-25.
http://dx.doi.org/10.1177/154405910708600903

 

7. Applequist SE, Wallin RP, Ljunggren HG. Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol. 2002;14:1065-74.
http://dx.doi.org/10.1093/intimm/dxf069

 

8. Arikan S, Durusoy C, Akalin N, Haberal A, Seckin D. Oxidant/antioxidant status in recurrent aphthous stomatitis. Oral diseases. 2009;15:512-5.
http://dx.doi.org/10.1111/j.1601-0825.2009.01580.x

 

9. Belenguer-Guallar I, Jimenez-Soriano Y, Claramunt-Lozano A. Treatment of recurrent aphthous stomatitis. A literature review. J Clin Exp Dent. 2014;6:e168-e74.
http://dx.doi.org/10.4317/jced.51401

 

10. Saral Y, Coskun BK, Ozturk P, Karatas F, Ayar A. Assessment of salivary and serum antioxidant vitamins and lipid peroxidation in patients with recurrent aphthous ulceration. Tohoku J Exp Med. 2005;206:305-12.
http://dx.doi.org/10.1620/tjem.206.305

 

11. Saha D, Sekhar KR, Cao C, Morrow JD, Choy H, Freeman ML. The antiangiogenic agent SU5416 down-regulates phorbol ester-mediated induction of cyclooxygenase 2 expression by inhibiting nicotinamide adenine dinucleotide phosphate oxidase activity. Cancer research. 2003;63:6920-7.

 

12. Zhang G, Liu X, Wang C, Qu L, Deng J, Wang H, et al. Resolution of PMA-induced skin inflammation involves interaction of IFN-gamma and ALOX15. Mediators Inflamm. 2013;2013:930124.
http://dx.doi.org/10.1155/2013/930124

 

13. Kemp K, Bruunsgaard H. Identification of IFN-gamma-producing CD4+ T cells following PMA stimulation. J Interferon Cytokine Res. 2001;21:503-6.
http://dx.doi.org/10.1089/10799900152434376

 

14. Bordon Y. Innate immunity: A COX detox for the immune system? Nat Rev Immunol.2014;14:358.
http://dx.doi.org/10.1038/nri3686

 

15. Palmer CD, Rahman FZ, Sewell GW, Ahmed A, Ashcroft M, Bloom SL, et al. Diminished macrophage apoptosis and reactive oxygen species generation after phorbol ester stimulation in Crohn's disease. PLoS One. 2009;4:e7787.
http://dx.doi.org/10.1371/journal.pone.0007787

 

16. Lee VM, Quinn PA, Jennings SC, Ng LL. Neutrophil activation and production of reactive oxygen species in pre-eclampsia. J Hypertens. 2003;21:395-402.
http://dx.doi.org/10.1097/00004872-200302000-00032

 

17. Ebisch IM, Thomas CM, Peters WH, Braat DD, Steegers-Theunissen RP. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update. 2007;13:163-74.
http://dx.doi.org/10.1093/humupd/dml054

 

18. Prasad AS. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care. 2009;12:646-52.
http://dx.doi.org/10.1097/MCO.0b013e3283312956

 

19. Carey LC, Berbee PL, Coyle P, Philcox JC, Rofe AM. Zinc treatment prevents lipopolysaccharide-induced teratogenicity in mice. Birth Defects Res A Clin Mol Teratol. 2003;67:240-5.
http://dx.doi.org/10.1002/bdra.10035

 

20. Haddad JJ. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro. Molecular immunology. 2009;47:205-14.
http://dx.doi.org/10.1016/j.molimm.2009.09.034

 

21. Takahashi M, Saito H, Higashimoto M, Hibi T. Possible inhibitory effect of oral zinc supplementation on hepatic fibrosis through downregulation of TIMP-1: A pilot study. Hepatology research : the official journal of the Japan Society of Hepatology. 2007;37:405-9.
http://dx.doi.org/10.1111/j.1872-034X.2007.00065.x

 

22. Kojima-Yuasa A, Ohkita T, Yukami K, Ichikawa H, Takami N, Nakatani T, et al. Involvement of intracellular glutathione in zinc deficiency-induced activation of hepatic stellate cells. Chem Biol Interact. 2003;146:89-99.
http://dx.doi.org/10.1016/S0009-2797(03)00087-5

 

23. Hammouda F, Messaoudi I, El Hani J, Baati T, Said K, Kerkeni A. Reversal of cadmium-induced thyroid dysfunction by selenium, zinc, or their combination in rat. Biological trace element research. 2008;126:194-203.
http://dx.doi.org/10.1007/s12011-008-8194-8

 

24. Nowak G, Siwek M, Dudek D, Zieba A, Pilc A. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Polish journal of pharmacology. 2003;55:1143-7.

 

25. Yan M, Song Y, Wong CP, Hardin K, Ho E. Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells. The Journal of nutrition. 2008;138:667-73.

 

26. Roth HP. Development of alimentary zinc deficiency in growing rats is retarded at low dietary protein levels. The Journal of nutrition. 2003;133:2294-301.

 

27. Rossi L, Migliaccio S, Corsi A, Marzia M, Bianco P, Teti A, et al. Reduced growth and skeletal changes in zinc-deficient growing rats are due to impaired growth plate activity and inanition. The Journal of nutrition. 2001;131:1142-6.

 

28. Karaca Z, Tanriverdi F, Kurtoglu S, Tokalioglu S, Unluhizarci K, Kelestimur F. Pubertal arrest due to Zn deficiency: the effect of zinc supplementation. Hormones (Athens). 2007;6:71-4.

 

29. Yagi T, Asakawa A, Ueda H, Ikeda S, Miyawaki S, Inui A. The role of zinc in the treatment of taste disorders. Recent Pat Food Nutr Agric. 2013;5:44-51.
http://dx.doi.org/10.2174/2212798411305010007

 

30. Najim RA, Sharquie KE, Abu-Raghif AR. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters. The Journal of dermatology. 2007;34:308-14.
http://dx.doi.org/10.1111/j.1346-8138.2007.00278.x

 

31. Lewkowicz N, Lewkowicz P, Banasik M, Kurnatowska A, Tchorzewski H. Predominance of Type 1 cytokines and decreased number of CD4(+)CD25(+high) T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations. Immunol Lett. 2005;99:57-62.
http://dx.doi.org/10.1016/j.imlet.2005.01.002

 

32. Chen YH, Zhao M, Chen X, Zhang Y, Wang H, Huang YY, et al. Zinc supplementation during pregnancy protects against lipopolysaccharide-induced fetal growth restriction and demise through its anti-inflammatory effect. J Immunol. 2012;189:454-63.
http://dx.doi.org/10.4049/jimmunol.1103579

 

33. Chua JS, Cowley CJ, Manavis J, Rofe AM, Coyle P. Prenatal exposure to lipopolysaccharide results in neurodevelopmental damage that is ameliorated by zinc in mice. Brain Behav Immun. 2012;26:326-36.
http://dx.doi.org/10.1016/j.bbi.2011.10.002

 

34. Gurel A, Altinyazar HC, Unalacak M, Armutcu F, Koca R. Purine catabolic enzymes and nitric oxide in patients with recurrent aphthous ulceration. Oral diseases. 2007;13:570-4.
http://dx.doi.org/10.1111/j.1601-0825.2006.01338.x

 

35. Cao ZA, Moore BB, Quezada D, Chang CH, Jones PP. Identification of an IFN-gamma responsive region in an intron of the invariant chain gene. Eur J Immunol. 2000;30:2604-11.
http://dx.doi.org/10.1002/1521-4141(200009)30:9<2604::AID-IMMU2604>3.0.CO;2-6

 

36. Bae YS, Hill ND, Bibi Y, Dreiher J, Cohen AD. Innovative uses for zinc in dermatology. Dermatol Clin. 2010;28:587-97.
http://dx.doi.org/10.1016/j.det.2010.03.006

 

37. Fivenson DP. The mechanisms of action of nicotinamide and zinc in inflammatory skin disease. Cutis. 2006;77:5-10.

 

38. Schwartz JR, Marsh RG, Draelos ZD. Zinc and skin health: overview of physiology and pharmacology. Dermatol Surg. 2005;31:837-47.
http://dx.doi.org/10.1111/j.1524-4725.2005.31729

 

39. Orbak R, Kara C, Ozbek E, Tezel A, Demir T. Effects of zinc deficiency on oral and periodontal diseases in rats. Journal of periodontal research. 2007;42:138-43.
http://dx.doi.org/10.1111/j.1600-0765.2006.00939.x

 

40. Klotz LO, Kroncke KD, Buchczyk DP, Sies H. Role of copper, zinc, selenium and tellurium in the cellular defense against oxidative and nitrosative stress. The Journal of nutrition. 2003;133:1448S-51S.

 

41. Chen CJ, Liao SL. Neurotrophic and neurotoxic effects of zinc on neonatal cortical neurons. Neurochem Int. 2003;42:471-9.
http://dx.doi.org/10.1016/S0197-0186(02)00154-7

 

42. Garrido G, Gonzalez D, Lemus Y, Garcia D, Lodeiro L, Quintero G, et al. In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (VIMANG). Pharmacol Res. 2004;50:143-9.
http://dx.doi.org/10.1016/j.phrs.2003.12.003

 

43. Chen BR, Cheng HH, Lin WC, Wang KH, Liou JY, Chen PF, et al. Quiescent fibroblasts are more active in mounting robust inflammatory responses than proliferative fibroblasts. PLoS One. 2012;7:e49232.
http://dx.doi.org/10.1371/journal.pone.0049232

 

44. McAdam BF, Mardini IA, Habib A, Burke A, Lawson JA, Kapoor S, et al. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest. 2000;105:1473-82.
http://dx.doi.org/10.1172/JCI9523

 

45. Orbak R, Cicek Y, Tezel A, Dogru Y. Effects of zinc treatment in patients with recurrent aphthous stomatitis. Dent Mater J. 2003;22:21-9.
http://dx.doi.org/10.4012/dmj.22.21

 

46. Ozturk P, Belge Kurutas E, Ataseven A. Copper/zinc and copper/selenium ratios, and oxidative stress as biochemical markers in recurrent aphthous stomatitis. J Trace Elem Med Biol. 2013;27:312-6.
http://dx.doi.org/10.1016/j.jtemb.2013.04.002

 

47. Seymour GJ, Gemmell E. Cytokines in periodontal disease: where to from here? Acta odontologica Scandinavica. 2001;59:167-73.
http://dx.doi.org/10.1080/000163501750266765

 

48. Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A, et al. Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Med Oral Patol Oral Cir Bucal. 2012;17:e10-5.
http://dx.doi.org/10.4317/medoral.17323

 

49. Tschopp J, Martinon F, Burns K. Nalps: a novel protein family involved in inflammation. Nature reviews. Molecular cell biology. 2003;4:95-104.
http://dx.doi.org/10.1038/nrm1019

 

50. Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF. The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol Immunol. 2009;24:11-7.
http://dx.doi.org/10.1111/j.1399-302X.2008.00467.x

 

51. Adler EP, Lemken CA, Katchen NS, Kurt RA. A dual role for tumor-derived chemokine RANTES (CCL5). Immunology letters. 2003;90:187-94.
http://dx.doi.org/10.1016/j.imlet.2003.09.013

 

52. Brown CE, Vishwanath RP, Aguilar B, Starr R, Najbauer J, Aboody KS, et al. Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells. J Immunol. 2007;179:3332-41.
http://dx.doi.org/10.4049/jimmunol.179.5.3332

 

53. Chang LY, Lin YC, Mahalingam J, Huang CT, Chen TW, Kang CW, et al. Peng Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res. 2012;72:1092-102.
http://dx.doi.org/10.1158/0008-5472.CAN-11-2493

 

54. Andrade I, Silva TA, Silva GA, Teixeira AL, Teixeira MM. The role of tumor necrosis factor receptor type 1 in orthodontic tooth movement. J Dent Res. 2007;86:1089-94.
http://dx.doi.org/10.1177/154405910708601113